IRadimed Corp
NASDAQ:IRMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IRadimed Corp
NASDAQ:IRMD
|
US |
|
Pharmagest Interactive SA
F:PHF
|
FR |
|
F
|
Feerum SA
WSE:FEE
|
PL |
|
S
|
Saigon Fuel JSC
VN:SFC
|
VN |
|
O
|
Oak Street Health Inc
F:HE6
|
US |
|
H
|
HocMon Trade JSC
VN:HTC
|
VN |
|
Paragon Care Ltd
ASX:PGC
|
AU |
|
Stevva Corp
OTC:STVA
|
GR |
|
Blue Ant Media Corp
TSX:BAMI
|
CA |
|
Incap Ltd
BSE:517370
|
IN |
|
R
|
R R Kabel Ltd
NSE:RRKABEL
|
IN |
Wall Street
Price Targets
IRMD Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for
IRMD
is 122.4 USD
with a low forecast of 121.2 USD and a high forecast of 126 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IRMD's stock price target?
Price Target
122.4
USD
According to Wall Street analysts, the average 1-year price target for
IRMD
is 122.4 USD
with a low forecast of 121.2 USD and a high forecast of 126 USD.
What is IRadimed Corp's Revenue forecast?
Projected CAGR
11%
For the last 12 years the
compound annual growth rate for
IRadimed Corp's revenue is
18%.
The projected
CAGR
for the next 2 years is
11%.
What is IRadimed Corp's Operating Income forecast?
Projected CAGR
15%
For the last 12 years the
compound annual growth rate for
IRadimed Corp's operating income is
20%.
The projected
CAGR
for the next 2 years is
15%.
What is IRadimed Corp's Net Income forecast?
Projected CAGR
16%
For the last 12 years the
compound annual growth rate for
IRadimed Corp's net income is
23%.
The projected
CAGR
for the next 2 years is
16%.
